Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Teijin discloses PDGF-inhibitory agents

Nov. 8, 1996

Teva generic drug licensed by FDA

Nov. 8, 1996

Nycomed discontinues development of antihypertensive drug

Nov. 8, 1996

Natural dual inhibitor of ECE and NEP described by Sankyo

Nov. 8, 1996

Potential antihypertensive agents reported by Kyowa Hakko

Nov. 8, 1996

cGMP-PDE inhibitors described by Sanofi Winthrop

Nov. 1, 1996

Antiarrhythmic 1,4-benzodiazepine from Merck

Nov. 1, 1996

Safer antiarrhythmic agent reported by Canadian researchers

Nov. 1, 1996

Hoechst claims new antiarrhythmic agents

Nov. 1, 1996

Atlantic's CT-1 and CT-2 prevent restenosis

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.